Search
InspireMD Inc
NSPRAdd to Watchlist
0.682USD
-0.018-2.51%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
31.97MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-01The current earnings forecast score of InspireMD Inc is 8.00, ranking 69 out of 204 in the Healthcare Equipment & Supplies industry. The average price target is 4.50, with a high of 5.00 and a low of 4.00.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
3.667
Target Price
+423.74%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
InspireMD Inc
NSPR
3
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
31
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is InspireMD Inc's expected revenue for the next quarter?
InspireMD Inc's expected revenue is 1.38M.
What is InspireMD Inc's price target?
Analysts forecast that InspireMD Inc's price target is USD 4.50, with the highest forecast at USD 5.00 and the lowest forecast at USD 4.00.
How have InspireMD IncNSPR's recent earnings per share performed?
The market expectation was USD -0.16, while InspireMD IncNSPR's earnings per share (EPS) for the previous quarter was USD -0.14. EPS for the next quarter is expected at USD -0.20.
What is the analyst rating for InspireMD Inc?
Based on the ratings of InspireMD Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.